MSFAX
Price
$34.87
Change
+$0.07 (+0.20%)
Updated
Oct 8 closing price
Net Assets
2.43B
RWIBX
Price
$75.10
Change
+$0.48 (+0.64%)
Updated
Oct 8 closing price
Net Assets
141.87B
Interact to see
Advertisement

MSFAX vs RWIBX

Header iconMSFAX vs RWIBX Comparison
Open Charts MSFAX vs RWIBXBanner chart's image
Morgan Stanley Inst Global Franchise I
Price$34.87
Change+$0.07 (+0.20%)
VolumeN/A
Net Assets2.43B
American Funds Capital World Gr&Inc R2
Price$75.10
Change+$0.48 (+0.64%)
VolumeN/A
Net Assets141.87B
MSFAX vs RWIBX Comparison Chart in %
View a ticker or compare two or three
VS
MSFAX vs. RWIBX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSFAX is a Buy and RWIBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 142B vs. MSFAX (2.43B). RWIBX pays higher dividends than MSFAX: RWIBX (0.76) vs MSFAX (0.65). MSFAX was incepted earlier than RWIBX: MSFAX (24 years) vs RWIBX (23 years). RWIBX (1.51) is less costly to investors than MSFAX (0.93). MSFAX is a more actively managed with annual turnover of: 35.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than MSFAX: RWIBX (250) vs MSFAX (1000000). RWIBX annual gain was more profitable for investors over the last year : 11.86 vs. MSFAX (-8.16). RWIBX return over 5 years is better than : 47.46 vs. MSFAX (14.75).
MSFAXRWIBXMSFAX / RWIBX
Total Expense Ratio0.931.5162%
Annual Report Gross Expense Ratio0.931.5162%
Fund Existence24 years23 years-
Gain YTD3.69520.70918%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.43B142B2%
Annual Yield % from dividends0.650.7686%
Returns for 1 year-8.1611.86-69%
Returns for 3 years27.4366.6741%
Returns for 5 years14.7547.4631%
Returns for 10 years70.1774.2794%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN21.360.36
+1.71%
Viridian Therapeutics
NYT55.270.41
+0.75%
New York Times Co
CUBWU10.57N/A
N/A
Lionheart Holdings
AMBI1.16-0.03
-2.52%
Ambipar Emergency Response
MAGN11.00-0.69
-5.90%
Magnera Corporation